Vial is a hyper-scalable biotech company advancing programs into the clinic by leveraging dramatically cheaper trials and computationally designed therapeutics.
Our mission is to reimagine drug development in order to cure all human diseases. We have assembled a talented team of clinical operators, chemists, and innovative thinkers to achieve this vision.
Vial is fully remote and was founded by Simon Burns in October 2020. Since our founding, we have grown rapidly to a team of 50+ employees with over $100 million in funding from leading investors including General Catalyst, Box Group, and Byers Capital.
Vial is rebuilding the infrastructure to advance research. By deploying technology at every step, we are creating a more efficient future for drug discovery.
Reporting into Vial Operations, we are seeking a Chief Medical Officer to join our team working on early-phase clinical trials. This role is pivotal in the Vial mission of making early stage Clinical Research an efficient, high quality engine and will play a critical role in bringing new life changing medicine to the market The ideal candidate will be adept at managing a high patient load and driving first in human trials to ensure the success of Vial therapeutics programs including Vial's IL-13 x TSLP for asthma, COPD and other pulmonary indications.
Creation of Clinical Development Plan and alignment with executive team
Engage with KOLs, investors and analysts on Vial's active trials and to share the clinical data
Oversee and maintain responsibility for the conduct of clinical trials
Collaborate with Vial Leadership and Site Lead for site success
Monitor and report on patient safety and overall status of clinical trials
Experience in pharma/biotech in clinical development, clinical operations or other relevant roles
Background in Immunology research or in clinical practice in Immunology, preferably in pulmonology
Passion for Clinical Research/Research and Development
Strong skills in time management, documentation, and patient care.
Experience with regulatory compliance for Clinical Trials.
Demonstrated success in scaling a clinical practice.
A passion for technology and innovation.
Innate curiosity.
At our core, we embody an insatiable curiosity. Our journey into the realm of clinical trials was ignited by a firsthand understanding of the challenges involved. This innate curiosity drives us to constantly innovate, seek fresh ideas, and bring our vision of reimagining clinical trials to life.
Fostering autonomy.
Autonomy is our guiding principle. We firmly believe that when team members are entrusted with autonomy, they unleash their true potential. Our culture fosters an environment where each individual takes ownership of their domain, empowering them to make a profound impact.
The pursuit of mastery.
We are dedicated to cultivating mastery. We understand the value of honing expertise in a craft. The pursuit of mastery, coupled with a deep sense of pride in one's workmanship, fuels our unwavering commitment to tackle intricate challenges. At Vial, we foster a culture of highly autonomous professionals, each an expert in their field, collaborating on an immensely demanding endeavor together.
Move fast, stay humble.
Our strength lies in agility and humility. We firmly believe that intellectual honesty and a nimble mindset are the pillars of success. By staying adaptable and open-minded to all solutions, we tackle obstacles head-on, remaining humble in the face of adversity. This enables us to surmount the hurdles that confront us at every twist and turn.
Competitive Salary (in AUD)
Competitive Equity Compensation
One time, Remote Office Setup Stipend
Remote-First, Flexible Work Schedule
Company Provided Laptop
We prioritize candidate safety. Please be aware that official communication will only be sent from @vial.com or @vial.careers addresses. Vial is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or veteran status.
